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ABSTRACT
Background: The importance of peanut allergy has not been well recognized in Japanese society. IgE anti-
body to peanut can be, however, detected in patients without clinical peanut allergy.
Methods: Clinical characteristics of 14 patients (aged 1―8 years) with peanut allergy were evaluated. IgE anti-
bodies to peanut from patients with and without clinical peanut allergy were compared with those to soybean
and other nuts. To examine the role of cross-reactive carbohydrate determinant (CCD) on the clinically false
positive detection of peanut IgE, horseradish peroxidase (HRP) and bromelain specific IgE were measured by
Uni CAP IgE kit. Inhibition of peanut IgE by HRP was also examined.
Results: The patients repeatedly experienced potentially life-threatening symptoms, including anaphylaxis.
Sera from patients with peanut allergy had negative or relatively low IgE antibodies to other nuts. However,
clinically false positive peanut IgE showed significant correlation-coefficients with soybean, almond, chestnut,
pistachio, macadamia and cashew (r = 0.61―1.00). Anti-HRP and anti-bromelain IgE antibodies were detected
in the clinically false positive sera, but not in the sera from patients with peanut allergy. Two out of four clinically
false positive peanut IgE antibodies were significantly inhibited by HRP.
Conclusions: Social education about the features of peanut allergy is needed in Japan. Anti-CCD IgE anti-
body was suggested to be one of the mechanisms contributing to the false positive detection of peanut IgE. De-
tection of anti-HRP or anti-bromelain IgE can be a useful tool to recognize the presence of anti-CCD antibodies.
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INTRODUCTION
Allergies to peanut account for the majority of fatal
and near-fatal anaphylactic reactions to foods.1 In the
United States, 3 million people are allergic to peanut
or tree nuts, and peanut-induced anaphylaxis causes
50 to 100 deaths per year.2 In Japan, peanut contrib-
utes to 2.4% of immediate type allergic reactions to
food.3 According to the results from this nation-wide
study, and because of the severity of allergic symp-
toms to peanut reported overseas, the Japanese Na-
tional Ministry of Health, Labor and Welfare desig-
nated peanut as one of the five major food allergens
required to be specified on the label of food products.
However, peanut allergy is not well understood in the
community, partially because of the lack of precise in-
formation about the prevalence or clinical importance
of peanut allergy among the Japanese population．
The first aim of this paper is to report the clinical
importance of peanut allergy in Japanese children ,
and allergic cross-reactivity of peanut to soybean and
other nuts．
Measurement of IgE antibody to peanut is a
screening test for diagnosis of peanut allergy. How-
ever, positive IgE antibody does not always indicate a
definitive diagnosis of peanut allergy.4 The presence
of IgE antibody to the carbohydrate (oligosaccharide)
moieties in the plant antigen is one of the well-known
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Table 1 Clinical features of peanut alergy
Total IgE
(IU/ml)
Other food alergiesSymptoms
First episode
(Years)
Age
(Years)
Peanut IgE
(UA/ml)
No
689milk, soybean (itch)Anaphylaxis x2, asthma＊3 6.7  1001
812milkAnaphylaxis, urticaria2 4.2  49.62
741milk, walnut (urticaria)Anaphylaxis x23.6  45.63
1180―Anaphylaxis6.1  10.34
608milk, eggsAnaphylaxis1 4.8  2.75
1918―Urticaria5.6  1006
8316―Urticaria, vomiting, diarhea2 5.0  85.67
307―Urticaria3 2.8  16.18
215
eggs, wheat, soybean (ur-
ticaria)
Urticaria1 2.1  8.179
26―Urticaria, abdominal pain2.8  110
583eggsErythema1 1.3  15.411
217―Erythema, itchy skin2 3.0  2.0112
203
eggs, gelatin, soybean 
(eczema)
Erythema3 8.2  1.0813
11270
milk, eggs, shrimp, choco-
late (eczema)
Eczema after 2 days　2.3  10014
＊Induced by prick-to-prick test with peanut buter 
Table 2 Clinical features of nut alergy.
Peanut alergy
Peanut IgE
(UA/ml)
Walnut IgE
(UA/ml)
SymptomsNuts
Age
(Years)
No
+45.60.35UrticariaWalnut31
-0.85.52AnaphylaxisWalnut, pine nut52
-2.20.65CoughWalnut23
-0.53.36AnaphylaxisWalnut34
-14.14.17UrticariaWalnut65
-3.44.21ErythemaMixed nuts†56
†Almond, cashew, walnut
mechanisms contributing to the clinically false posi-
tive detection of IgE antibodies.5 The common struc-
tures of N-linked glycan in plants (fruits, vegetables
and pollens) have been well characterized and desig-
nated as cross-reactive carbohydrate determinant
(CCD).6 Natural Ara h 1, the major peanut allergen,
has a single N-glycosylation site bearing five glycan
species in a one to one ratio.7
The second aim of this paper is to investigate the
role of anti-CCD IgE antibodies in the clinically false
positive IgE antibodies to peanut, soybean and other
nuts．
METHODS
Fourteen patients ( aged 1―8 years , mean ± SD :
4.17 ± 2.0 years) with apparent history of immediate
type peanut allergy were recruited to reveal the clini-
cal characteristics of peanut allergy. Six patients with
tree nut allergy (aged 2―6 years, 4.63 ± 1.69 years)
were also analyzed. Oral challenge tests were not al-
ways performed to confirm the diagnosis, because se-
vere anaphylaxis might occur in those with peanut
and tree nut allergy.1
Sera from the 14 patients with peanut allergy and 8
patients without clinical peanut allergy despite the de-
tection of IgE to peanut (designated as clinically false
positive sera) were served for measurement of IgE
antibodies to other nuts by UniCAP specific IgE kit
(Pharmacia Diagnostics AB, Sweden). The nuts ex-
amined were soybean, walnut, almond, cashew nut,
chestnut , pistachio , macadamia and pine nut , al-
though some data were lacking due to the limitations
of the sera obtained．
Four representative sera from patients with peanut
allergy and four clinically false positive sera were ex-
amined for IgE antibodies to horseradish peroxidase
(HRP)8 and bromelain (from pineapple stem)9 by
UniCAP specific IgE kit. The UniCAP inhibition test
was also performed using peanut ImmunoCAP and
HRP (Sigma P6782, St. Louis, MO, USA) as an inhibi-
tor. HRP contains 6 N-linked glycans and bromelain
carries only one IgE-binding glycan.10
Informed consent was obtained from parents of the
subjects to donate their sera for this study.
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Fig. 1　Corelation of IgE antibodies to peanut and other nuts. Closed circles indicate 
sera from patients with peanut alergy, and open circles indicate sera from patients without 
peanut alergy. Pearson’ scorelation-coeficient was calculated only with the clinicaly 
false positive sera.
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RESULTS
The clinical symptoms of 14 patients with peanut al-
lergy were mostly severe, including anaphylaxis ( n =
5) , systemic urticaria (n = 5 ) , erythema (n = 3 ) ,
asthma and gastrointestinal symptoms (Table 1). The
severity of symptoms was compatible to that reported
in the United States or European countries.1 Most of
the patients had their first episode at 1―3 years of
age. Although the parents were careful to avoid any
food contaminated with peanut , some patients re-
peated the symptoms by eating processed foods such
as curry , sandwiches and crackers ( contamination
from the manufacturing line), or by contact to nut-
shells．
Three patients were also allergic to soybean, but
the symptoms were mild and consisted of atypical im-
mediate reactions (eczema, urticaria) . One patient
had an allergy to walnut (urticaria), but IgE antibody
to walnut was negative．
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Fig. 2　IgE antibodies to HRP and bromelain in the sera 
from patients with and without peanut alergy.
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Six patients had allergies to other nuts, including
walnut (n = 5), pine nut (n = 1) and mixed nuts (al-
mond, cashew and walnut, n = 1), which caused ana-
phylaxis (n = 2), urticaria (n = 2) and cough(n = 1).
Only one patient was cross-reactive to peanut (Ta-
ble 2).Although most of the patients avoided peanut
and tree nuts, clinical cross-reactivity between peanut
and other tree nuts was not common．
Correlations of IgE antibodies between peanut and
other nuts are shown in Figure 1. Most of the sera
from patients with peanut allergy had negative IgE to
walnut, chestnut, macadamia, almond and pine nut.
Although IgE antibody to soybean was positive in
most of the patients with peanut allergy, IgE antibody
to peanut was higher than that to soybean . These
data suggested that IgE antibody from patients with
peanut allergy tend to bind to the peanut-specific epi-
tope which did not cross-react to other nuts．
On the other hand , clinically false positive sera
showed significant correlation-coefficients between
IgE antibodies to peanut and soybean (r = 0.98, p =
0.0024), almond (r = 1.00, p = 0.0003), chestnut (r =
0.87, p = 0.0011) , pistachio (r = 0.83, p = 0.0029 ) ,
macadamia (r = 0.61, p = 0.0406) and cashew (r = 0.67,
p = 0.0233). These data suggested that false positive
peanut IgE recognized the common structure be-
tween peanut and these nuts. No significant correla-
tion was observed between clinically false positive
IgE to peanut and walnut or pine nut (Fig. 1).
Anti-CCD IgE antibodies were measured to reveal
one of the mechanisms of the clinically false positive
IgE to peanut. Anti-HRP and anti-bromelain IgE were
detected in 4 representative sera from patients with-
out peanut allergy . However , the 4 representative
sera from patients with peanut allergy showed nega-
tive IgE to HRP and bromelain (Fig. 2).
IgE inhibition tests showed that pre-incubation of
the sera with HRP significantly abrogated IgE bind-
ing to peanut in 2 of the 4 sera with false positive pea-
nut IgE in a dose-dependent manner. Another serum
showed partial (40%) inhibition, and the other was not
inhibited. These findings suggested that CCD might
contribute to the clinically false positive peanut IgE in
some patients. On the other hand, no inhibition was
observed in the sera from any of the 4 patients with
peanut allergy (Fig. 3).
DISCUSSION
In the United States and Europe, many authors have
emphasized the importance of peanut allergy because
of the life-threatening symptoms and increasing num-
ber of affected patients.1,2 The prevalence of peanut
allergy in the Japanese population is not clear. Here
we report on 14 children with peanut allergy in our
clinic. This number was compatible to that of buck-
wheat, fish or shrimp allergy in our clinic (data not
shown). The severity of allergic symptoms of each pa-
tient was similar to that reported previously, and the
patients repeatedly experienced potentially life-
threatening symptoms．
It is known that almost 30% of patients with peanut
allergy also respond to other tree nuts.11 Our findings
also suggested that 28.6% (4 out of 14) patients with
peanut allergy reacted to soybean or walnut . How-
ever, the reactions to soybean observed in the 3 cases
were not typical immediate-type responses, such as
worsening of eczema．
Ara h 1, the major peanut allergen, belongs to the
cupin superfamily, named vicilin.12 Although homolo-
gous proteins exist in the other legume families,12 pa-
tients with peanut allergy had no or relatively lower
IgE antibodies to other tree nuts or soybean. These
findings suggested the presence of peanut-specific
epitopes that are preferentially recognized by IgE an-
tibodies of patients with peanut allergy．
Shin et al. reported that three Ara h 1 molecules as-
semble to form a highly stable trimeric complex, 13
and IgE-binding epitopes are clustered near the re-
gions of monomer-monomer contact.14 According to
this trimeric structure , Ara h 1 may possess resis-
tance to protease digestion, and the increased num-
ber of IgE-binding epitopes in one molecule may in-
duce a strong release of chemical mediators from
mast cells. Cross-reactivity of this trimeric Ara h 1 be-
tween homologous proteins of other tree nuts may be
of interest．
On the other hand, IgE antibody to peanut can be
detected from atopic patients without clinical symp-
toms to peanut. The presence of IgE antibody to the
carbohydrate moiety (CCD) is a well-known mecha-
nism to explain the detection of clinically false posi-
tive IgE to plant allergens.6 Figure 4 shows the struc-
tures of N-linked glycans of HRP, bromelain and Ara
h 1. Common structures of glycans have been charac-
terized from a variety of plant allergens.15 The pres-
ence of β(1, 2)-Xylose and α(1, 3)-Fucose residues
linked to the core MannGlcNAc2 backbone is known
to contribute to the IgE binding.16 Anti-CCD IgE anti-
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Fig. 3　Peanut IgE inhibition tests with HRP, a representative CCD antigen. Individual sera from 4 pa-
tients with and without peanut alergy were pre-incubated with the indicated concentrations of HRP, and 
peanut IgE antibodies were detected by UniCAP. Percent inhibition of peanut IgE titers are shown.
n = 4n = 4
100
80
40
60
20
0
100
80
40
60
20
0
10-4 10-3 10-2 10-1 1 1010-4 10-3 10-2 10-1 1 10
Peanut allergy (+)
%
 in
hi
bi
tio
n
Inhibitor (mg/ml) Inhibitor (mg/ml)
Peanut allergy (-)
Fig. 4　Structures of the N-linked glycans known as cross-reactive carbohydrate determinant (CCD). Bromelain from pine-
apple stem has one xylose-containing N-linked glycan (MUXF). Horseradish peroxidase (HRP) has 6 xylose and fucose-
containing glycans (MMXF). Ara h 1 has one glycosylation site bearing either one of the 5 oligosaccharides (MMX, Man4X, 
Man4, Man5, Man6).
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bodies have poor biologic activity in terms of weak
basophil histamine release and negative skin prick
tests,4 because CCD on a monoglycosylated allergen
can not cross-link high-affinity IgE receptors on mast
cells and basophils. Van der Veen et al. have reported
that positive IgE antibodies to peanut without clinical
symptoms were the consequence of anti-CCD IgE
that cross-reacted to peanut and grass-pollen aller-
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gens.17
Our findings also support the idea that anti-CCD
IgE antibodies contribute to the clinically false posi-
tive IgE antibodies to peanut and tree nuts in some
patients. In general, anti-CCD IgE antibody binds to
multiple plant allergens including pollens, vegetables,
fruits and nuts. Care should be taken to consider the
presence of anti-CCD IgE in the sera with positive
IgE antibodies to multiple allergens, especially in the
Japanese clinical practice where detection of IgE anti-
bodies is more commonly used than skin prick tests
or oral food challenge for the screening of food al-
lergy．
Detection of anti-HRP or anti-bromelain IgE by
UniCAP is a practical tool for the detection of anti-
CCD IgE. Furthermore, the RAST inhibition test may
be required to confirm the presence of CCD in the al-
lergen. In the present study, one false positive serum
showed negative inhibition of peanut IgE with HRP,
suggesting that CCD is not always the feature of clini-
cally false positive IgE．
In conclusion, peanut allergy causes severe, some-
times life-threatening reactions in Japanese children.
Social education about the importance of peanut al-
lergy is needed. However, detection of IgE antibody
to peanut does not always indicate a definitive diagno-
sis of peanut allergy, and the presence of anti-CCD
IgE antibody should be considered in a case of multi-
ple positive IgE antibodies to plant allergens, includ-
ing peanut．
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